MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹529 Cr | ₹459 Cr | ₹339 Cr | ₹259 Cr | ₹340 Cr |
What is the latest Operating Profit of MARKSANS PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹529 Cr |
| Mar2024 | ₹459 Cr |
| Mar2023 | ₹339 Cr |
| Mar2022 | ₹259 Cr |
| Mar2021 | ₹340 Cr |
How is Operating Profit of MARKSANS PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹529 Cr | 15.28 | |
| Mar2024 | ₹459 Cr | 35.15 | |
| Mar2023 | ₹339 Cr | 31.07 | |
| Mar2022 | ₹259 Cr | -23.77 | |
| Mar2021 | ₹340 Cr | - | |
Compare Operating Profit of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹8,021.6 Cr | -2.6% | 4.8% | -27.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,054.0 Cr | 0.9% | 6.2% | -1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,075.0 Cr | 2% | 4.8% | 4.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,904.0 Cr | 3.6% | 6% | 36.9% | Stock Analytics | |
| CIPLA | ₹107,358.0 Cr | -0.1% | -3% | -8.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,813.0 Cr | 1% | 10.8% | 4.7% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -2.6% |
4.8% |
-27.4% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses